Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fibrosis × Tocopherols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomatitis 1 Small Cell Lung Carcinoma 1 Osteoradionecrosis 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Fibrosis 1 Drug-Related Side Effects and Adverse Reactions 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Female 1

Interventions

Blood Specimen Collection 8 Magnetic Resonance Spectroscopy 5 Liver Transplantation 4 Tenofovir 3 Specimen Handling 3 Pentoxifylline 3 High-Energy Shock Waves 3 Sorafenib 2 Simvastatin 2 Low-Level Light Therapy 2 Gemcitabine 2 tremelimumab 1 sonidegib 1 sofosbuvir-velpatasvir drug combination 1 ruxolitinib 1 peginterferon alfa-2a 1 navitoclax 1 maltodextrin 1 hepatitis B hyperimmune globulin 1 esmolol 1 epigallocatechin gallate 1 durvalumab 1 contrast agent BR1 1 bavituximab 1 atezolizumab 1 apixaban 1 alpha-Tocopherol 1 adefovir dipivoxil 1 Viusid 1 Vitamin E 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01822405 2013-04-02

ORT-OXI-2009

Hospital Universitario de Canarias

Phase 2 Unknown

Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡